Clinical Evaluation Masterclass: Appraisal of literature sources has not been conducted properly - Episode 2

Dr Paul Hercock

A non-conformity in clinical evaluation arises when a Clinical Evaluation Plan (CEP) or Report (CER) fails to meet regulatory standards or Notified Body (NB) expectations.

These deficiencies such as incomplete data, unclear safety criteria, or inadequate evidence analysis indicate that the device’s safety and performance are not sufficiently demonstrated, requiring correction before approval.

For manufacturers, such non-conformities can result in delayed approvals, extended review cycles, and costly rework, as unresolved issues block NB acceptance. Proactively addressing non-conformities helps streamline audits, accelerate certifications, and strengthen regulatory compliance, ensuring smoother market access.

This video series breaks down the most common clinical evaluation non-conformities, explains why they keep happening, and most importantly, shows you how to fix (or avoid) them for good.

Episode 2: “Appraisal of literature sources has not been conducted properly”

One of the most frequent reasons for CER rejection is poor appraisal of literature sources. In this episode, we cover:

  • What ‘appraisal’ really means and the purpose it serves
  • Key characteristics of an appropriately conducted appraisal process
  • How to practically implement appraisals during clinical evaluation and why it matters

A well-documented appraisal strategy is essential for demonstrating safety and performance through clinical data. Ensuring the appraisal is systematic, objective, and traceable can significantly reduce regulatory pushback.

If you missed it, be sure to check out Episode 1:”Safety and Performance Objectives Lack Specific and measurable acceptance criteria” where we explore how to define specific, measurable objectives and develop practical acceptance criteria that meet Notified Body expectations.

Stay tuned for Episode 3, where tackle another common non-conformity: “It is not clear what systematic search methods were used for the literature review.” We’ll show you how to design and document a compliant search strategy that ensures transparency, traceability, and relevance in your literature review process. Sign up to our newsletter now so you don’t miss out.


Transcript follows:

It’s Paul from Mantra Systems here, and welcome to episode two of our series on how to fix clinical evaluation non-conformances.

If you didn’t see the first part in the series, I’ll put a link to that post in the description below this video.

But otherwise, let’s get on with episode two.


Non-conformances following submission of a clinical evaluation are quite common under the EU MDR, basically because the standard for submissions is now so high.

But the problem is that:

  • Resolution of non-conformances is necessary for the clinical evaluation to be accepted.
  • Nonconformities can be quite difficult to interpret.
  • It may not always be clear how to fully address them.
  • A failure to resolve non-conformances may lead to:
    • A further round of review,
    • Increased costs,
    • Lost time,
    • Stress and worry.

The aim of this series is to work through commonly seen nonconformities one at a time, and dig deep into what they mean and how to solve—or preferably avoid—them in the first place.

The context behind this is to link into general principles for optimal conduct of medical device clinical evaluation.

Nonconformity Number Two. The one we’re going to look at is this:

‘Appraisal of literature articles has not been conducted appropriately.’

This is one we see a lot. To explore it—and ensure that you don’t fall foul of it—we’ve broken our approach down into three steps:

  1. Consider what appraisal actually means and what purpose it serves within the context of a clinical evaluation.
  2. Look at the characteristics of an appropriate appraisal framework.
  3. Consider how appraisal should be applied during clinical evaluation.

What Is Appraisal? Appraisal is:

  • A structured and systematic evaluation of:
    • The quality of individual studies within a literature review or a clinical evaluation, and
    • The relevance of each source to the clinical evaluation.

If applied correctly, appraisal enables systematic weighting of study outcomes according to quality and relevance.

The basic idea:

The better the study, and the more relevant it is, the greater weighting is given to its results compared with lower-quality studies of lower relevance.

The MEDDEV guideline 2.7/1 revision 4—although somewhat outdated—places appraisal effectively into context.

  • Clinical evaluation is split into four stages: 0, 1, 2, and 3.
  • Appraisal is stage 2, which:
    • Comes after identification of pertinent data,
    • Leads into appropriate analysis,
    • Emphasizes that you can’t properly analyze data until you’ve appraised it.

Designing an Appraisal Framework. There is no universally defined appraisal system. Some systems are broadly accepted, such as the Oxford scheme, but:

  • These can be limited. For example, the Oxford scheme only considers study type, overlooking other relevant factors.
  • Therefore, justification of your chosen method is key.

Appraisal should:

  • Consider a range of factors related to study quality and relevance.
  • Avoid being based on just one or two elements.

The most common pitfall: doing nothing with the appraisal.

The objective is to produce an appraisal score for each source that actively influences outcomes.

This score becomes a mathematical weighting factor applied to results from individual sources.

Characteristics of a Compliant Appraisal Framework. There’s no universally accepted method, but an appraisal scheme may consider:

  • Study type
    • RCTs typically score higher than cohort studies or case series.
  • Sample size
    • Larger sample sizes increase reliability and therefore the score.
  • Use of statistics
    • Includes whether the study shows statistical significance.
    • Well-designed statistical analysis increases score.
  • Length of follow-up
    • Longer follow-up captures more of the clinical journey.
  • Devices used within studies
    • Subject device: highest score
    • Equivalent device: slightly lower
    • Similar device: lower still
    • Unrelated device: lowest score

The key is justification—explain to the reviewer why your approach is appropriate.

Example Scoring Framework. In your appraisal protocol, you might use a system like this:

  • Characteristics listed on the left
  • Descriptions and alpha-numeric grading on the right
  • Higher numbers = better scores

Example:

  • A randomized control trial might be scored R4.
  • A case series might be scored R1.

You can build a table with these scores and apply it to each study. This allows a study to be:

  • Strong in one area,
  • Weak in another.

This combined appraisal system accounts for nuance.

To produce the overall appraisal score, add the numbers in each row.

Example (hypothetical data):

For ‘Jones et al’:
R3 (3) + 2 + 1 + 3 + 3 = 12

Applying the Appraisal. Once you have appraisal scores:

  1. List the studies and their appraisal scores.
  2. Add an outcome parameter (e.g., reduction in pain VAS).

To calculate the weighted mean:

  • Multiply the outcome value by the appraisal score.
  • Example for Jones et al:
    • Outcome: 4.5
    • Appraisal score: 12
    • Weighted value: 4.5 × 12 = 54

Repeat for each source.

Then:

  • Sum the appraisal scores: 61
  • Sum the weighted values: 226.7
  • Divide the total weighted values by the total appraisal scores:
Weighted mean = 226.7 / 61 = 3.72

This gives greater weight to better quality studies, which is the essence of how appraisal is expressed in a compliant clinical evaluation.

Summary of an Effective appraisal:

  • Uses systematic methods to evaluate quality and relevance.
  • Considers a range of factors.
  • Produces a score to enable mathematical weighting of results.
  • Must be:
    • Justified,
    • Conducted according to a clear, advance plan.
  • Applies to literature for both:
    • Subject devices,
    • State-of-the-art comparisons.

Recap of Episode Two: Nonconformity #2: Appraisal of literature articles has not been conducted appropriately

In this episode, we’ve:

  • Looked at what appraisal is and what purpose it serves.
  • Considered characteristics of an appropriately conducted appraisal process.
  • Looked at how appraisal should be applied during clinical evaluation and the effect it has on outcomes.

Don’t forget that Mantra Systems offers a comprehensive clinical evaluation service. One of the most common reasons we’re engaged is to help with resolution of non-conformities.

  • All initial conversations are completely free.
  • We have a really friendly team.
  • Give us a call or send us an email if you’d like to discuss anything.

That concludes episode two in this non-conformity series.

Please share if you found this video useful, and I look forward to seeing you in the next part of the series.

Thank you very much!

Related articles

  1. A lone figure navigates a rocky coastline.

    Navigating CAPA Terminology: Key Terms for Medical Device Professionals

    We define and explain the language required to work within a Quality Management System (QMS).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  2. Video poster frame for Episode 1 of our new series.

    Clinical Evaluation Masterclass: Overcoming Non-conformities - Episode 1

    In this series, we work step-by-step through common Non-Conformities to ensure you are always ahead of possible challenges on the way to MDR approval.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  3. A man carefully steps across a cliff-face. An analogy for assessing risk.

    Top 5 Common Pitfalls to Avoid During Risk Assessment

    Learn how to sidestep costly mistakes which manufacturers commonly make. From hazard ID to post-market surveillance, we help you improve safety and speed up approvals.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  4. A label maker printing bar-code labels.

    Labelling 101: A Comprehensive Overview for Medical Device Manufacturers

    Labelling and packaging are critical elements to ensuring safety, compliance, and ease of use.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  5. An illustration of a brain-shaped object on an abstract background.

    European Commission Guidelines on Prohibited Artificial Intelligence Practices

    Summary of the 8 AI practices prohibited by the EU 2024/1689 artificial intelligence (AI) Act.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  6. A compass being used to navigate across mountainous countryside.

    Navigating Non-Conformities in Technical Documentation

    We explore how to manage non-conformities effectively and implement Corrective and Preventive Actions (CAPAs).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  7. A photograph of a literal maze that we're using as a clever metaphor.

    Mastering the EU MDR: Essential Steps for Compliance-Ready Docs

    If you're uncertain about the readiness of your EU MDR documentation, this article provides an overview of the essential steps to ensure you’re on track.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  8. An illustration showing scientists at work.

    A Guide to Electronic Instructions for Use (eIFU)

    Electronic Instructions for Use (eIFUs) are set to revolutionise how medical device instructions are delivered. We explore what this means for you.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  9. Two helicopters look as if they are about to collide: An analogy for risk.

    Navigating Risk Management Requirements under the EU MDR

    This is a cornerstone of EU MDR 2017/745, requiring a continuous, well-documented approach. We unpack key requirements and provide actionable strategies.

    Peter Boxall Peter Boxall Lead Medical Writer
  10. A doctor operates a tablet computer.

    Beyond the Acronyms: Understanding SaMD and SiMD

    As software advancements continue, the line between traditional hardware-centric medical devices and software-driven solutions becomes increasingly blurred.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  11. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  12. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  13. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  14. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  15. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  16. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  17. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  18. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  19. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  20. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  21. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  22. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  23. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  24. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  25. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  26. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  27. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  28. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  29. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  30. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  31. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  32. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  33. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  34. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  35. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  36. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  37. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  38. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  39. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  40. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  41. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  42. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  43. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  44. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  45. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  46. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  47. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  48. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  49. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today